John G. Hanly
NS, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications
The lupus damage index revision program: Results from the item generation and reduction phases.
Journal: Lupus science & medicine
Published: July 30, 2026
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.
Journal: Arthritis care & research
Published: November 14, 2025
Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.
Journal: Lupus science & medicine
Published: October 17, 2025
Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.
Journal: Journal of clinical epidemiology
Published: June 20, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 22, 2025
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Journal: Annals of the rheumatic diseases
Published: May 06, 2025
Towards a minimal core dataset for systemic lupus erythematosus studies.
Journal: Lupus science & medicine
Published: March 19, 2025
An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.
Journal: Rheumatology (Oxford, England)
Published: January 28, 2025
Publisher Correction: Recent advances in the diagnosis and management of neuropsychiatric lupus.
Journal: Nature reviews. Rheumatology
Published: November 13, 2024
Recent advances in the diagnosis and management of neuropsychiatric lupus.
Journal: Nature reviews. Rheumatology
Published: August 19, 2024
Last Updated: 09/26/2026